Alx Historical Financial Ratios
| ALXO Stock | USD 1.31 0.15 10.27% |
Alx Oncology is presently reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.19 or Days Sales Outstanding of 44.57 will help investors to properly organize and evaluate Alx Oncology Holdings financial condition quickly.
Alx |
About Alx Financial Ratios Analysis
Alx Oncology HoldingsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Alx Oncology investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Alx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Alx Oncology history.
Alx Oncology Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Alx Oncology Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Alx Oncology sales, a figure that is much harder to manipulate than other Alx Oncology Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Alx Oncology Holdings dividend as a percentage of Alx Oncology stock price. Alx Oncology Holdings dividend yield is a measure of Alx Oncology stock productivity, which can be interpreted as interest rate earned on an Alx Oncology investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Alx Oncology's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Alx Oncology Holdings current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, Alx Oncology's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 31st of January 2025, Research And Ddevelopement To Revenue is likely to grow to 23.15, while Book Value Per Share is likely to drop 3.25.
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 9.57 | 5.24 | 6.03 | 5.73 | Net Debt To EBITDA | 2.23 | 0.0329 | 0.0378 | 0.0359 |
Alx Oncology fundamentals Correlations
Click cells to compare fundamentals
Alx Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Alx Oncology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alx Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will appreciate offsetting losses from the drop in the long position's value.Moving against Alx Stock
| 0.58 | JNJ | Johnson Johnson | PairCorr |
| 0.45 | KRYS | Krystal Biotech | PairCorr |
| 0.45 | PDSB | PDS Biotechnology Corp | PairCorr |
| 0.37 | NKTX | Nkarta Inc | PairCorr |
| 0.31 | INZY | Inozyme Pharma | PairCorr |
The ability to find closely correlated positions to Alx Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alx Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alx Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alx Oncology Holdings to buy it.
The correlation of Alx Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alx Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alx Oncology Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alx Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.